Elisa Scarselli
Company: Nouscom
Job title: Chief Scientific Officer
Seminars:
Uncovering the Best Strategies to Employ Neoantigen Vaccines for the Most Effective Therapies 5:00 pm
Utilizing marine models to identify the patient profiles that are most effective for personalized cancer vaccines Exploring the timing and dosage schedule of personalized cancer vaccines to improve translation to the clinic Determining the optimal combination therapy strategy with personalized vaccines for better cancer treatmentRead more
day: Conference Day One
Panel Discussion: Personalized vs Off-the-shelf Cancer Vaccines: Evaluating the Advantages & Disadvantages for Better Clinical Efficacy 3:00 pm
Debating the feasibility of individualized cancer vaccines vs targeting shared neoantigens Highlighting successes in personalized cancer vaccines that prove clinical efficacy and viability Considering the future opportunities for cancer vaccines in personalized & off-the-shelf for positive patient responseRead more
day: Pre-Conference Focus Day